[{"id":"ea493a38-566a-4e48-88f7-f0d01f7afdcd","acronym":"","url":"https://clinicaltrials.gov/study/NCT02405221","created_at":"2021-01-29T07:07:56.363Z","updated_at":"2024-07-02T16:35:41.311Z","phase":"Phase 1","brief_title":"Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer","source_id_and_acronym":"NCT02405221","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PVX2"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 14","initiation":"Initiation: 04/04/2019","start_date":" 04/04/2019","primary_txt":" Primary completion: 03/31/2024","primary_completion_date":" 03/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-08-01"}]